Author:
Kojo H,Nishida M,Goto S,Kuwahara S
Abstract
Antibacterial activity of FK 749 against ampicillin-resistant clinical isolates of Escherichia coli was compared with those of other newly developed cephalosporins. FK 749 was the most active against strains possessing R-plasmids specifying ampicillin resistance and those whose resistance was chromosomally determined. The susceptibility of ampicillin-susceptible E. coli to FK 749 was not decreased by transduction of ampicillin resistance-specifying plasmids. However, most of the transconjugants acquired a high level of resistance to cefoperazone and cefamandole and a moderate level of resistance to cefoperazone and cefamandole and a moderate level to cefotiam. FK 749 was highly stable to both penicillinase- and cephalosporinase-type beta-lactamases, including R-plasmid-mediated beta-lactamase. Its level of resistance to beta-lactamases was comparable to those of cefoxitin, cefmetazole, and cefotaxime, slightly superior to that of cefuroxime, and much superior to those of cefotiam, cefamandole, and cefoperazone.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference8 articles.
1. Recommendation on the determination of minimal inhibitory concentration (MIC);Committee on MIC of Japan Society of Chemotherapy.;Chemotherapy (Tokyo),1975
2. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae;Datta N.;Nature (London),1965
3. Gram-negative bacilli: its resistance and the superinfection;Goto S.;Jpn. J. Bacteriol.,1976
4. Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities;Kamimura T.;Antimicrob. Agents Chemother.,1979
5. The drug sensitivities of gram-negative bacilli isolated from urinary tract infections from 1972 with particular reference to cephalosporins and aminoglycosides;Matsumoto F.;Chemotherapy (Tokyo),1976
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献